Policy
The $1.2 trillion budget package will now move to the Senate, which is expected to hold a vote next week.
FEATURED STORIES
An inconsistent boom-and-bust cycle funding environment for early-stage biotech innovations and burdensome regulation threaten the U.S.’s half-century-long dominance in the biotech sector.
Acadia Pharma’s Catherine Owen Adams is one of the founders of a group of small- to mid-cap biotechs advocating against a ‘peanut butter blanket’ approach to drug pricing for small companies.
Former European Trade Commissioner Phil Hogan and former US Senator Richard Burr, speaking on a panel at the J.P. Morgan Healthcare Conference, pushed to see a larger picture beyond the Trump administration’s year of chaos and confusion.
Subscribe to BioPharm Executive
Market insights and trending stories for biopharma leaders, in your inbox every Wednesday
THE LATEST
Shanghai Green Valley Pharmaceuticals announced that China’s National Medical Products Administration has approved Oligomannate as new drug for the treatment of mild to moderate Alzheimer’s disease.
Researchers with the National Institute on Aging published research of a gene variant, APO3 Christchurch (APOE3ch), that appears to confer resistance to Alzheimer’s disease.
Endorsement of pivotal development program in recurrent glioblastoma (rGBM) from both EMA and FDA
AVEO said it received preliminary feedback from the FDA and the regulatory agency recommended not filing the NDA at this time based on its assessment of the totality of evidence in the Phase III trial.
Late Friday, President Donald Trump put forth Hahn’s name to take over the top spot of the nation’s regulatory agency.
An international team of researchers have put forward a position statement, published in Science, whichlays out a new healthcare framework to help aging populations stay healthier for longer.
Reston Hospital Center has recently renewed accreditation as a Center of Excellence in Minimally Invasive Gynecology by Surgical Review Corporation This accreditation distinguishes Reston Hospital Center from many other surgical facilities by providing the highest quality of care to patients as determined by an independent, external process of evaluation.
Centrient Pharmaceuticals, the global leader in the production and commercialisation of sustainable antibiotics, next generation statins and anti-fungals, is proud to announce it has received a Gold Sustainability rating from EcoVadis.
A disappointed Merck said it was reviewing its options for a possible appeal, while a pleased Gilead said if an appeal came, it was confident a higher court would come to the same verdict as the federal appeals court.
As Nancy Pelosi’s drug pricing reform bill winds its way through the House toward an expected full vote in coming days, life sciences organizations are marshalling their forces in opposition to what they see as innovation-killing legislation.